Alunbrig (brigatinib)
pCPA File Number:
21143
Negotiation Status:
Negotiations were not pursued
Indication(s):
Non-Squamous Non-Small Cell Lung Cancer
Sponsor/Manufacturer:
Takeda Canada Inc.
CDA-AMC Project Number:
PC0167-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded: